Replies

Don't you think it's up to Rush to back up his own statements.

He's got a big staff, he should be posting his documentation on his website in real time.

Flu Vaccine Shortage is Due to Low Price Not Manufacturing Problems

Widespread national reports of a flu vaccine shortage due to manufacturing problems and plant shutdowns are simply not true. The real cause of the shortage is the flu vaccine's low price.

The whole process of producing, selling and distributing flu vaccine is complicated. It not only involves manufacturers and distributors, but the World Health Organization who annually determines the formula. Manufacturers must wait for their recommendation to complete production of the vaccine. Most contracts for fall delivery of the vaccine are made early in the spring, long before the recommendation for the final strain has been announced.

Manufacturers begin producing vaccine in the winter with a limited amount of marketing and production data. At prices ranging from $2.00 to $3.00 per dose, quantities of vaccines that are not sold or returned at the end of the season can turn a manufacturer's annual profit into a loss. As a result each manufacturer produces only what they know they can sell.

Any negative variation in the actual production of the flu vaccine results in a market shortage during the critical months of September and October. By the time manufacturers learn their original projections are off, it is difficult to quickly make up the shortage. Chicken eggs are a critical component of the vaccine, and it is hard to make chickens lay several hundred thousand eggs on short notice.

Don't you think it's up to Rush to back up his own statements.

Actually, it's also up to you to prove him otherwise. So let's hear it.

Until then, I'm sticking with Rush on this.